ロード中...
Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion
BACKGROUND: Non Muscle Invasive Bladder Transitional Cancer (NMIBC) and Muscle Invasive Bladder Transitional Cancer (MIBC)/invasive have different gene profile and clinical course. NMIBC prognosis is not completely predictable, since the relapse rate is higher than 20%, even in the form of MIBC. The...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2014
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4061920/ https://ncbi.nlm.nih.gov/pubmed/24893613 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-33-48 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|